Now, keep up to date
with daily feeds of newly posted stories
about America's Seniors...click on the box
to the left
Men with
Wives, Significant Others more likely to be
screened for Prostate Cancer
Newswise — Although the link between early screening and
prostate cancer survival is well
established, men are less likely to go for
early screening unless they have a wife or
significant other living with them,
according to a study published in Cancer
Epidemiology, Biomarkers and Prevention,
a journal of the American Association for
Cancer Research.
“In terms of motivating people to get screened, there may
be benefit in targeting wives or significant
others as well as men,” said lead author
Lauren P. Wallner, M.P.H., a graduate
research associate at the University of
Michigan.
Prostate cancer is the second leading cause of cancer
deaths among men in the United States, and
early detection is associated with
drastically improved five-year survival
rates.
However, what motivates a man to get screened is not known.
Wallner and colleagues identified 2,447 Caucasian men ages
40 years to 79 years from Olmstead County,
Minnesota.
These men completed questionnaires containing queries on
family history of prostate cancer, concern
about getting prostate cancer and marital
status.
If men had a family history of prostate cancer, they were
50 percent more likely to be screened. If
men said they were worried about prostate
cancer, they were nearly twice as likely to
be screened.
However, the likelihood among men with a family history to
get screened decreased if they lived alone.
Specifically, men who lived alone were 40 percent less
likely to be screened than those who were
married or had a significant other in their
home.
Wallner said the study did not assess what caused a married
man to be more likely to be screened. She
also said that further studies would need to
examine this effect in non-Caucasian
populations.
The mission of the American Association for Cancer Research
is to prevent and cure cancer.
Founded in 1907, AACR is the world’s oldest and largest
professional organization dedicated to
advancing cancer research.
The membership includes more than 28,000 basic,
translational and clinical researchers;
health care professionals; and cancer
survivors and advocates in the United States
and 80 other countries.
The AACR marshals the full spectrum of expertise from the
cancer community to accelerate progress in
the prevention, diagnosis and treatment of
cancer through high-quality scientific and
educational programs. It funds innovative,
meritorious research grants.
The AACR Annual Meeting attracts more than 17,000
participants who share the latest
discoveries and developments in the field.
Special conferences throughout the year
present novel data across a wide variety of
topics in cancer research, treatment and
patient care.
The AACR publishes five major peer-reviewed journals:
Cancer Research; Clinical Cancer Research;
Molecular Cancer Therapeutics; Molecular
Cancer Research; and Cancer Epidemiology,
Biomarkers & Prevention.
The AACR’s most recent publication and its sixth
major journal, Cancer Prevention Research,
is dedicated exclusively to cancer
prevention, from preclinical research to
clinical trials.
The AACR also publishes CR, a magazine for cancer survivors
and their families, patient advocates,
physicians and scientists. CR provides a
forum for sharing essential, evidence-based
information and perspectives on progress in
cancer research, survivorship and advocacy.
... ..
...
...